CERo Therapeutics Holdings Inc. [NASDAQ: CERO] stock went on an upward path that rose over 6.28% on Thursday, amounting to a one-week price increase of more than 4.97%.
Over the last 12 months, CERO stock dropped by -97.03%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $4.58 million, with 15.06 million shares outstanding and 6.98 million shares in the current float. Compared to the average trading volume of 1.35M shares, CERO stock reached a trading volume of 2310292 in the most recent trading day, which is why market watchdogs consider the stock to be active.
CERO Stock Performance Analysis:
CERo Therapeutics Holdings Inc. [CERO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.97. With this latest performance, CERO shares dropped by -71.28% in over the last four-week period, additionally sinking by -97.21% over the last 6 months – not to mention a drop of -97.03% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CERO stock in for the last two-week period is set at 24.19, with the RSI for the last a single of trading hit 23.97, and the three-weeks RSI is set at 26.52 for CERo Therapeutics Holdings Inc. [CERO]. The present Moving Average for the last 50 days of trading for this stock 0.9806, while it was recorded at 0.3177 for the last single week of trading, and 6.5217 for the last 200 days.
Insight into CERo Therapeutics Holdings Inc. Fundamentals:
CERo Therapeutics Holdings Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.47 and a Current Ratio set at 0.47.
CERo Therapeutics Holdings Inc. [CERO] Institutonal Ownership Details
The top three institutional holders of CERO stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in CERO stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in CERO stock with ownership which is approximately 5.8386%.
